Get the Stockscreener App
0.00
100.00%
-8.05
After Hours:
8.09
8.09
+
Vigil Neuroscience Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
See More
Previous Close:
$8.05
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$375.71M
Revenue:
-
Net Income/Loss:
$-82.60M
P/E Ratio:
0.00
EPS:
-2.06
Net Cash Flow:
$-48.61M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$8.10
Vigil Neuroscience Inc Stock (VIGL) Company Profile
Name
Vigil Neuroscience Inc
Sector
Industry
Phone
857-254-4445
Address
100 FORGE ROAD, WATERTOWN
Compare VIGL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VIGL
Vigil Neuroscience Inc
|
0.00 | 375.71M | 0 | -82.60M | -48.61M | -2.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
417.21 | 108.30B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
652.91 | 69.37B | 14.25B | 4.58B | 3.56B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.59 | 62.38B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
821.97 | 51.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.95 | 34.94B | 398.11M | -1.03B | -868.57M | -5.7032 |
Vigil Neuroscience Inc Stock (VIGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-25 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Initiated | William Blair | Outperform |
| Dec-19-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-18-23 | Initiated | JMP Securities | Mkt Outperform |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Sep-16-22 | Initiated | Wedbush | Outperform |
| Aug-29-22 | Initiated | H.C. Wainwright | Buy |
| Feb-01-22 | Initiated | Guggenheim | Buy |
| Feb-01-22 | Initiated | Jefferies | Buy |
| Feb-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-01-22 | Initiated | Stifel | Buy |
View All
Vigil Neuroscience Inc Stock (VIGL) Latest News
What institutional flow reveals about Vigil Neuroscience Inc.2025 Geopolitical Influence & Accurate Buy Signal Alerts - newser.com
Best data tools to analyze Vigil Neuroscience Inc. stock2025 Stock Rankings & Technical Pattern Based Signals - newser.com
Smart tools for monitoring Vigil Neuroscience Inc.’s price action2025 Price Targets & Technical Pattern Based Buy Signals - newser.com
Using portfolio simulators with Vigil Neuroscience Inc. includedJuly 2025 Decliners & High Return Stock Watch Alerts - newser.com
What indicators show strength in Vigil Neuroscience Inc.Volume Spike & Long-Term Safe Investment Plans - newser.com
Does Vigil Neuroscience Inc. stock trade at a discount to peersQuarterly Profit Summary & Low Risk Entry Point Tips - newser.com
Will Vigil Neuroscience Inc. stock deliver strong dividend growthJuly 2025 News Drivers & Verified Swing Trading Watchlist - newser.com
Predicting Vigil Neuroscience Inc. trend using moving averages2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com
Why Vigil Neuroscience Inc. is moving todayPortfolio Value Report & Low Drawdown Investment Strategies - newser.com
Using Bollinger Bands to evaluate Vigil Neuroscience Inc.2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Is this a good reentry point in Vigil Neuroscience Inc.Trade Volume Report & Low Risk High Win Rate Stock Picks - newser.com
Vigil Neuroscience Inc Stock (VIGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
1.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):